Source 1primary paper2026MED
Toolkit/circular RNA
circular RNA
Also known as: circRNA, circRNAs
Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
New methodologies such as circular RNA (circRNAs) ...
Usefulness & Problems
Why this is useful
Circular RNA is listed as a new RNA therapeutic methodology within the expanded RNA therapeutics landscape.; next-generation RNA therapeutic modality; Circular RNAs are named as an emerging RNA therapeutic modality. The abstract includes them in the set of approaches expected to expand the therapeutic landscape.; emerging RNA therapeutic modality exploration
Source:
Circular RNA is listed as a new RNA therapeutic methodology within the expanded RNA therapeutics landscape.
Source:
next-generation RNA therapeutic modality
Source:
Circular RNAs are named as an emerging RNA therapeutic modality. The abstract includes them in the set of approaches expected to expand the therapeutic landscape.
Source:
emerging RNA therapeutic modality exploration
Problem solved
The abstract supports their relevance as a future-facing RNA modality, but does not specify a distinct problem solved.
Source:
The abstract supports their relevance as a future-facing RNA modality, but does not specify a distinct problem solved.
Problem links
The abstract supports their relevance as a future-facing RNA modality, but does not specify a distinct prob...
LiteratureThe abstract supports their relevance as a future-facing RNA modality, but does not specify a distinct problem solved.
Source:
The abstract supports their relevance as a future-facing RNA modality, but does not specify a distinct problem solved.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Component: A low-level RNA part used inside a larger architecture that realizes a mechanism.
Mechanisms
durable protein expressionTechniques
No technique tags yet.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
The abstract does not specify implementation requirements for circular RNAs. It only indicates that further exploration is needed.; requires further exploration
No modality-specific limitation is given in the abstract. Broader field challenges such as delivery, safety, and scalability still apply.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
These new-generation RNA therapeutic systems extend therapeutic applications to oncology, neurology, metabolic disease, and rare genetic disorders.
New-generation RNA therapeutic systems including circRNA, saRNA, splice-switching ASOs, small-molecule splicing modulators, and ADAR-directed base editors can enable durable protein expression, reversible transcript recoding, and precision splicing modulation.
Extrahepatic delivery is advancing through ligand-targeted LNPs, peptide conjugates, and engineered exosomes.
AI-enhanced design is accelerating optimization of RNA sequences, chemistries, and vectors.
Recent clinical achievements in RNA therapeutics, including COVID-19 mRNA vaccination, were enabled by backbone chemistry, nucleoside modifications, and targeted delivery including GalNAc conjugation and LNP encapsulation.
Approval Evidence
2 sources3 linked approval claimsfirst-pass slugs circular-rna, circular-rnas
New methodologies such as circular RNA (circRNAs) ...
Source:
To fully realize this potential, the field must prioritize the development of robust regulatory frameworks and adaptive clinical trial designs to ensure equitable access, while also advancing exploration of emerging modalities such as circular RNAs, self-amplifying RNAs, and RNA-targeting small molecules.
Source:
application scopesupports
These new-generation RNA therapeutic systems extend therapeutic applications to oncology, neurology, metabolic disease, and rare genetic disorders.
Source:
capabilitysupports
New-generation RNA therapeutic systems including circRNA, saRNA, splice-switching ASOs, small-molecule splicing modulators, and ADAR-directed base editors can enable durable protein expression, reversible transcript recoding, and precision splicing modulation.
Source:
emerging modalitysupports
Circular RNAs and self-amplifying RNAs are emerging modalities being advanced to expand the RNA therapeutic landscape.
Source:
Comparisons
Source-stated alternatives
The abstract mentions self-amplifying RNAs and RNA-targeting small molecules as other emerging modalities.
Source:
The abstract mentions self-amplifying RNAs and RNA-targeting small molecules as other emerging modalities.
Source-backed strengths
identified as an emerging modality
Source:
identified as an emerging modality
Compared with self-amplifying RNA vaccines
The abstract mentions self-amplifying RNAs and RNA-targeting small molecules as other emerging modalities.
Shared frame: source-stated alternative in extracted literature
Strengths here: identified as an emerging modality.
Source:
The abstract mentions self-amplifying RNAs and RNA-targeting small molecules as other emerging modalities.
Ranked Citations
- 1.